Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_501834ccb229d70e0b1979889dbe15ba |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-49 |
filingDate |
2020-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c01b561e27ecc1ce6bf6d69bcc53e68 |
publicationDate |
2022-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3941469-A1 |
titleOfInvention |
Methods of treating negative symptoms of schizophrenia using deuterated dextromethorphan and quinidine |
abstract |
The present disclosure relates to methods of treating negative symptoms of schizophrenia. The methods include administering to a patient having schizophrenia deuterated [d6]-dextromethorphan hydrobromide in combination with quinidine sulfate. Compositions useful for treating negative symptoms of schizophrenia are also disclosed. |
priorityDate |
2019-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |